том 55 издание 4 страницы 1490-1499

3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A2B Adenosine Receptor Antagonists

Тип публикацииJournal Article
Дата публикации2012-02-07
SCImago Q1
Tоп 10% SCImago
WOS Q1
БС1
SJR1.726
CiteScore11.1
Impact factor7.3
ISSN00222623, 15204804
Drug Discovery
Molecular Medicine
Краткое описание
In an effort to identify novel ligands possessing high affinity and selectivity for the A(2B) AR subtype, we further investigated the class of 3-aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones V, previously disclosed by us as selective A(1) AR antagonists. Preliminary assays on a number of triazinobenzimidazoles derived from our "in-house" collection revealed that all the derivatives selected showed significant affinity at A(2B) AR, no affinity at A(3) AR, and various degrees of selectivity toward A(1) and A(2A) ARs. Investigation of a new series featuring modified substituents at the 10-position (4'-chlorophenyl or phenylethyl groups), and a chlorine atom at the 7-position (X) of the triazinobenzimidazole nucleus, yielded highly potent and selective A(2B) AR antagonists. The presence of a pendant 3-phenyl ring appears to hamper the interaction with A(2A) AR, conferring high A(2B)/A(2A) AR selectivity. Derivative 13 (X = Cl, R = C(6)H(5)) is the most potent and selective compound, with an IC(50) of 3.10 nM at A(2B) AR and no affinity at A(1), A(2A), and A(3) ARs.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.

Топ-30

Журналы

1
2
3
4
5
Journal of Medicinal Chemistry
5 публикаций, 15.63%
Molecules
4 публикации, 12.5%
Arabian Journal of Chemistry
2 публикации, 6.25%
Archiv der Pharmazie
2 публикации, 6.25%
Russian Chemical Bulletin
2 публикации, 6.25%
Molecular and Cellular Biochemistry
1 публикация, 3.13%
Chemistry of Heterocyclic Compounds
1 публикация, 3.13%
PLoS ONE
1 публикация, 3.13%
Nuclear Medicine and Biology
1 публикация, 3.13%
Bioorganic Chemistry
1 публикация, 3.13%
European Journal of Medicinal Chemistry
1 публикация, 3.13%
Biochimica et Biophysica Acta - General Subjects
1 публикация, 3.13%
Bioorganic and Medicinal Chemistry
1 публикация, 3.13%
ACS Medicinal Chemistry Letters
1 публикация, 3.13%
Green Chemistry
1 публикация, 3.13%
Progress in Medicinal Chemistry
1 публикация, 3.13%
Topics in Medicinal Chemistry
1 публикация, 3.13%
Synthesis
1 публикация, 3.13%
International Journal of Molecular Sciences
1 публикация, 3.13%
Journal of Organic Chemistry
1 публикация, 3.13%
1
2
3
4
5

Издатели

1
2
3
4
5
6
7
Elsevier
7 публикаций, 21.88%
American Chemical Society (ACS)
7 публикаций, 21.88%
MDPI
5 публикаций, 15.63%
Springer Nature
5 публикаций, 15.63%
King Saud University
2 публикации, 6.25%
Wiley
2 публикации, 6.25%
Public Library of Science (PLoS)
1 публикация, 3.13%
Royal Society of Chemistry (RSC)
1 публикация, 3.13%
Georg Thieme Verlag KG
1 публикация, 3.13%
1
2
3
4
5
6
7
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
 Войти с ORCID
Метрики
32
Поделиться
Цитировать
ГОСТ |
Цитировать
Taliani S. et al. 3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A2B Adenosine Receptor Antagonists // Journal of Medicinal Chemistry. 2012. Vol. 55. No. 4. pp. 1490-1499.
ГОСТ со всеми авторами (до 50) Скопировать
Taliani S., Pugliesi I., Barresi E., Simorini F., Salerno S., La Motta C., Marini A., Cosimelli B., Cosconati S., Maro S. D., Marinelli L., Daniele S., Trincavelli M. L., GRECO G. M., Novellino E., Martini C., Da Settimo F. 3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A2B Adenosine Receptor Antagonists // Journal of Medicinal Chemistry. 2012. Vol. 55. No. 4. pp. 1490-1499.
RIS |
Цитировать
TY - JOUR
DO - 10.1021/jm201177b
UR - https://doi.org/10.1021/jm201177b
TI - 3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A2B Adenosine Receptor Antagonists
T2 - Journal of Medicinal Chemistry
AU - Taliani, Sabrina
AU - Pugliesi, Isabella
AU - Barresi, Elisabetta
AU - Simorini, Francesca
AU - Salerno, Silvia
AU - La Motta, Concettina
AU - Marini, Anna
AU - Cosimelli, Barbara
AU - Cosconati, Sandro
AU - Maro, Salvatore Di
AU - Marinelli, Luciana
AU - Daniele, Simona
AU - Trincavelli, Maria Letizia
AU - GRECO, GIOVANNI M.
AU - Novellino, Ettore
AU - Martini, Claudia
AU - Da Settimo, Federico
PY - 2012
DA - 2012/02/07
PB - American Chemical Society (ACS)
SP - 1490-1499
IS - 4
VL - 55
PMID - 22257095
SN - 0022-2623
SN - 1520-4804
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2012_Taliani,
author = {Sabrina Taliani and Isabella Pugliesi and Elisabetta Barresi and Francesca Simorini and Silvia Salerno and Concettina La Motta and Anna Marini and Barbara Cosimelli and Sandro Cosconati and Salvatore Di Maro and Luciana Marinelli and Simona Daniele and Maria Letizia Trincavelli and GIOVANNI M. GRECO and Ettore Novellino and Claudia Martini and Federico Da Settimo},
title = {3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A2B Adenosine Receptor Antagonists},
journal = {Journal of Medicinal Chemistry},
year = {2012},
volume = {55},
publisher = {American Chemical Society (ACS)},
month = {feb},
url = {https://doi.org/10.1021/jm201177b},
number = {4},
pages = {1490--1499},
doi = {10.1021/jm201177b}
}
MLA
Цитировать
Taliani, Sabrina, et al. “3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A2B Adenosine Receptor Antagonists.” Journal of Medicinal Chemistry, vol. 55, no. 4, Feb. 2012, pp. 1490-1499. https://doi.org/10.1021/jm201177b.
Ошибка в публикации?